Skip to main content
Clinical Trials/NCT01121445
NCT01121445
Unknown
Not Applicable

The Impact of Daily Sinus Irrigation on Nasal Symptoms in Continuous Positive Airway Pressure (CPAP) Users - A Pilot Study

Bridgeport Hospital1 site in 1 country30 target enrollmentMay 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Bridgeport Hospital
Enrollment
30
Locations
1
Primary Endpoint
RQLQ (Rhinoconjunctivitis Quality of Life Questionnaire)
Last Updated
15 years ago

Overview

Brief Summary

Continuous positive airway pressure (CPAP) is the most commonly used treatment for obstructive sleep apnea. Nasal symptoms such as dryness, itching and congestion are common in CPAP users. Nasal and sinus saline irrigation has been shown to improve these symptoms in individuals with chronic nasal congestion and sinusitis. This is an 8 week study that investigates whether daily saline nasal and sinus irrigation reduces nasal symptoms in patients using CPAP, improves quality of life and CPAP compliance.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
March 2011
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Apnea/hypopnea index ≥ 10
  • A documented successful CPAP titration

Exclusion Criteria

  • Conditions that in the judgment of the investigator would interfere with subject participation in the study
  • History of sinus or nasal surgery
  • History of psychiatric illness
  • Use of sleep aids, sedatives or narcotics
  • Use of oral of subcutaneous anti-coagulants (i.e. warfarin, enoxaparin)
  • Bilevel or other nocturnal ventilation other than CPAP
  • Use of supplemental oxygen
  • Pregnancy or lactating
  • Inability or unwillingness to provide informed consent
  • Inability to perform baseline measurements

Outcomes

Primary Outcomes

RQLQ (Rhinoconjunctivitis Quality of Life Questionnaire)

Time Frame: 4 weeks

A 28-item, self administered questionnaire measuring nasal symptoms and other domains, including activity limitations and eye symptoms. Subjects will be asked to rate their symptoms on a 7-point scale (0=no impairment, 6=severely impaired). Change in RQLQ with daily saline irrigation in CPAP users is the primary outcome of interest.

Secondary Outcomes

  • Epworth Sleepiness Scale(4 weeks)
  • SF-36(4 weeks)
  • CPAP compliance(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials